119 related articles for article (PubMed ID: 7964975)
1. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.
Rao JS; Steck PA; Tofilon P; Boyd D; Ali-Osman F; Stetler-Stevenson WG; Liotta LA; Sawaya R
J Neurooncol; 1994; 18(2):129-38. PubMed ID: 7964975
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Spheroid Invasion through Soft, Brain-Like Matrices Depends on Hyaluronic Acid-CD44 Interactions.
Safarians G; Sohrabi A; Solomon I; Xiao W; Bastola S; Rajput BW; Epperson M; Rosenzweig I; Tamura K; Singer B; Huang J; Harrison MJ; Sanazzaro T; Condro MC; Kornblum HI; Seidlits SK
Adv Healthc Mater; 2023 Jun; 12(14):e2203143. PubMed ID: 36694362
[TBL] [Abstract][Full Text] [Related]
3. Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives.
Seker-Polat F; Pinarbasi Degirmenci N; Solaroglu I; Bagci-Onder T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053605
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear factor-κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies.
Tu J; Fang Y; Han D; Tan X; Jiang H; Gong X; Wang X; Hong W; Wei W
Cell Prolif; 2021 Feb; 54(2):e12929. PubMed ID: 33300633
[TBL] [Abstract][Full Text] [Related]
5. Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomas.
Kawal P; Chandra A; Rajkumar ; Dhole TN; Ojha B
Asian J Neurosurg; 2016; 11(2):160-6. PubMed ID: 27057223
[TBL] [Abstract][Full Text] [Related]
6. Diphtheria toxin-based targeted toxin therapy for brain tumors.
Li YM; Vallera DA; Hall WA
J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
[TBL] [Abstract][Full Text] [Related]
7. Targeted toxins in brain tumor therapy.
Li YM; Hall WA
Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
[TBL] [Abstract][Full Text] [Related]
8. Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice.
Ponnala S; Veeravalli KK; Chetty C; Dinh DH; Rao JS
PLoS One; 2011; 6(10):e26191. PubMed ID: 22022560
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
[TBL] [Abstract][Full Text] [Related]
10. Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population.
Malik N; Kumar R; Prasad KN; Kawal P; Srivastava A; Mahapatra AK
J Neurooncol; 2011 May; 102(3):347-52. PubMed ID: 20706772
[TBL] [Abstract][Full Text] [Related]
11. H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.
Zhao Y; Xiao A; Dipierro CG; Abdel-Fattah R; Amos S; Redpath GT; Carpenter JE; Pieper RO; Hussaini IM
Glia; 2008 Jun; 56(8):917-24. PubMed ID: 18383343
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
Wang M; Yoshida D; Liu S; Teramoto A
J Neurooncol; 2005 Mar; 72(1):1-9. PubMed ID: 15803368
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.
Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
[TBL] [Abstract][Full Text] [Related]
14. Proteases and the biology of glioma invasion.
Binder DK; Berger MS
J Neurooncol; 2002 Jan; 56(2):149-58. PubMed ID: 11995816
[TBL] [Abstract][Full Text] [Related]
15. "...those left behind." Biology and oncology of invasive glioma cells.
Berens ME; Giese A
Neoplasia; 1999 Aug; 1(3):208-19. PubMed ID: 10935475
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms.
Jäälinojä J; Herva R; Korpela M; Höyhtyä M; Turpeenniemi-Hujanen T
J Neurooncol; 2000; 46(1):81-90. PubMed ID: 10896208
[TBL] [Abstract][Full Text] [Related]
17. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Rooprai HK; Rucklidge GJ; Panou C; Pilkington GJ
Br J Cancer; 2000 Jan; 82(1):52-5. PubMed ID: 10638966
[TBL] [Abstract][Full Text] [Related]
18. Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
Morrissey D; O'Connell J; Lynch D; O'Sullivan GC; Shanahan F; Collins JK
Clin Exp Metastasis; 1999 Feb; 17(1):77-85. PubMed ID: 10390151
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Ree AH; Bjørnland K; Brünner N; Johansen HT; Pedersen KB; Aasen AO; Fodstad O
Clin Exp Metastasis; 1998 Apr; 16(3):205-15. PubMed ID: 9568638
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro.
Li H; Shimura H; Aoki Y; Date K; Matsumoto K; Nakamura T; Tanaka M
Clin Exp Metastasis; 1998 Jan; 16(1):74-82. PubMed ID: 9502079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
